{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220629",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 2/3",
          "submission_class_code_description": "Type 2 - New Active Ingredient and Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "71496",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/215429Orig1s000,215429Orig2s000ltr.pdf",
              "date": "20220630",
              "type": "Letter"
            },
            {
              "id": "71499",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215429s000lbl.pdf",
              "date": "20220630",
              "type": "Label"
            },
            {
              "id": "71501",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215429s000lbl.pdf#page=31",
              "date": "20220630",
              "type": "Medication Guide"
            },
            {
              "id": "73637",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/215152Orig1s000,215153Orig1s000TOC.html",
              "date": "20230301",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230818",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "75201",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215429s001lbl.pdf",
              "date": "20230822",
              "type": "Label"
            },
            {
              "id": "75202",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215429s001lbl.pdf#page=33",
              "date": "20230822",
              "type": "Medication Guide"
            },
            {
              "id": "75237",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/215429Orig1s001ltr.pdf",
              "date": "20230822",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20220629",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 2/3",
          "submission_class_code_description": "Type 2 - New Active Ingredient and Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "71497",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/215429Orig1s000,215429Orig2s000ltr.pdf",
              "date": "20220630",
              "type": "Letter"
            },
            {
              "id": "71498",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215429s000lbl.pdf",
              "date": "20220630",
              "type": "Label"
            },
            {
              "id": "71500",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215429s000lbl.pdf#page=31",
              "date": "20220630",
              "type": "Medication Guide"
            },
            {
              "id": "73636",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/215152Orig1s000,215153Orig1s000TOC.html",
              "date": "20230301",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA215429",
      "sponsor_name": "ALMATICA",
      "openfda": {
        "application_number": [
          "NDA215429"
        ],
        "brand_name": [
          "VENLAFAXINE"
        ],
        "generic_name": [
          "VENLAFAXINE"
        ],
        "manufacturer_name": [
          "Almatica Pharma LLC"
        ],
        "product_ndc": [
          "52427-632"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "VENLAFAXINE BESYLATE MONOHYDRATE"
        ],
        "rxcui": [
          "2605950"
        ],
        "spl_id": [
          "1b0762be-0db0-b997-b76b-b212a496f82c"
        ],
        "spl_set_id": [
          "e81a2daf-b8b2-7c05-b532-bc775700b100"
        ],
        "package_ndc": [
          "52427-632-30"
        ],
        "unii": [
          "18XP3YT5NH"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "VENLAFAXINE BESYLATE",
          "active_ingredients": [
            {
              "name": "VENLAFAXINE BESYLATE",
              "strength": "EQ 112.5MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}